https://www.selleckchem.com/products/md-224.html
99), MI (OR 0.65, 95% CI 0.44-0.95) and TVR (OR 0.86, 95% CI 0.74-1.0 were lower with AT compared to cPCI. The risk of ST and stroke was no different with the use of adjunctive AT. MBG, STR, and LVEF improved with the use of AT while the infarct size was no different in the two groups. Our comprehensive network meta-analysis suggests conflicting outcomes with AT. While Mortality, MACE, MI seem better, there is a suggestion that, Stroke and ST might be worse. Whether AT can still be pursued in any select cases should be further scrutini
Like
Comment
Share
